Jarrett Jennifer
Reporting owner on Forms 3, 4 and 5, CIK 1671311.
Jarrett Jennifer reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-28.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Damora Therapeutics, Inc. CIK 1800315 | director, officer (Director, President and CEO) | 1 | 2026-09-28 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. Ordinary Shares | 2026-09-25 | P bought | +12,500 | $20.23 | 512,500 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-403355 | Damora Therapeutics, Inc. | 2026-09-28 |